cagrilintide weight loss Novo Nordisk's shows promising in REDEFINE-1 sub-analysis, unveiled at EASD 2025 Cagrilintide – Weight Loss &

A., Siegel, S

Yes, these drugs were originally developed for type 2 diabetes but are now widely used for weight management because they reliably reduce appetite and induce significant weight loss

(iv) without history of cerebral infarction/hemorrhage or other known nervous system disease

2015 Jan;69(1):1-2

Cardiovascular Risk The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that testosterone replacement did not increase the rate of major adverse cardiovascular events in middle-aged and older men with hypogonadism and high cardiovascular risk (HR 1.02, 95% CI 0.84 to 1.24)